Dividend Channel
Free Dividend Report - Top Ranked Stocks

PARTNER NEWS:

Thu, Apr 11, 8:15 AM, Zacks
Alkermes' (ALKS) ALKS 2680 Betters Wakefulness in Phase Ib Study
Alkermes (ALKS) reports positive top-line data from a phase Ib, proof-of-concept study investigating ALKS 2680 for the treatment of narcolepsy.

Fri, Apr 5, 3:33 AM, Zacks
Merck (MRK) Begins Phase III NSCLC Study on KRAS Candidate
Merck's (MRK) phase III study will evaluate KRAS G12C inhibitor candidate MK-1084 for first-line treatment of certain patients with metastatic NSCLC.

Featured MNV Articles:

COMPASS Pathways (CMPS) Shares Cross Below 200 DMA
Thursday, April 18, 4:58 PM ET, by Market News Video Staff

In trading on Thursday, shares of COMPASS Pathways plc (CMPS) crossed below their 200 day ...

AnaptysBio Breaks Below 200-Day Moving Average - Notable for ANAB
Thursday, April 18, 4:56 PM ET, by Market News Video Staff

In trading on Thursday, shares of AnaptysBio Inc (ANAB) crossed below their 200 day moving ...

Notable Two Hundred Day Moving Average Cross - CERT
Thursday, April 18, 4:56 PM ET, by Market News Video Staff

In trading on Thursday, shares of Certara Inc (CERT) crossed below their 200 day moving ...

WhiteHorse Finance Breaks Above 200-Day Moving Average - Bullish for WHF
Thursday, April 18, 4:46 PM ET, by Market News Video Staff

In trading on Thursday, shares of WhiteHorse Finance Inc. (WHF) crossed above their 200 day ...

RBC Bearings Enters Oversold Territory
Thursday, April 18, 4:45 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
Play Video: The Importance of ETFs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts


Dividend Channel | www.DividendChannel.com | Copyright © 2010 - 2024, All Rights Reserved

Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.